Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126348951 | 12634895 | 1 | I | 20160729 | 0 | 20160808 | 20160808 | DIR | 64.00 | YR | N | 287.00000 | LBS | 20160805 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126348951 | 12634895 | 1 | PS | TAMSULOSIN HCL 0.4 MG CAP, 0.4 MG SUN | TAMSULOSIN | 1 | Oral | Y | D | 20170430 | 0 | 90 | DF | CAPSULE | HS | ||||
| 126348951 | 12634895 | 3 | C | LOSARTAN. | LOSARTAN | 1 | 0 | ||||||||||||
| 126348951 | 12634895 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 126348951 | 12634895 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 126348951 | 12634895 | 9 | C | AGGRENOX | ASPIRINDIPYRIDAMOLE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126348951 | 12634895 | 1 | Pollakiuria |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126348951 | 12634895 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126348951 | 12634895 | Dry eye | |
| 126348951 | 12634895 | Tooth disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126348951 | 12634895 | 1 | 20160729 | 20160802 | 0 |